Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMOP
BNY Mellon Municipal Opportunities ETF
BMOP
|
+$1.73B |
| 2 |
BKMI
BNY Mellon Municipal Intermediate ETF
BKMI
|
+$1.63B |
| 3 |
AstraZeneca
AZN
|
+$1.19B |
| 4 |
Texas Instruments
TXN
|
+$836M |
| 5 |
FITB
Fifth Third Bancorp
FITB
|
+$744M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$2.06B |
| 2 |
Apple
AAPL
|
+$1.49B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
Bank of America
BAC
|
+$859M |
| 5 |
TSMC
TSM
|
+$824M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.98% |
| 2 | Financials | 11.85% |
| 3 | Healthcare | 10.11% |
| 4 | Industrials | 9.34% |
| 5 | Consumer Discretionary | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2401
ARKO Corp
ARKO
$544M
| $4.28M | ﹤0.01% |
769,641
-2,432
| -0.3% | -$13.6K |
|
2402
Mativ Holdings
MATV
$674M
| $4.27M | ﹤0.01% |
491,368
+1,311
| +0.3% | +$15K |
|
2403
SGHC Ltd
SGHC
$6.76B
| $4.27M | ﹤0.01% |
395,517
-12,436
| -3% | -$127K |
|
2404
First Trust Active Factor Large Cap ETF
AFLG
$738M
| $4.27M | ﹤0.01% |
110,709
+33,401
| +43% | +$1.33M |
|
|
AVNS
2405
DELISTED
Avanos Medical
AVNS
| $4.27M | ﹤0.01% |
304,726
-1,351
| -0.4% | -$18.2K |
|
2406
First Mid Bancshares
FMBH
$1.38B
| $4.27M | ﹤0.01% |
103,578
-1,641
| -2% | -$68K |
|
2407
CNB Financial Corp
CCNE
$1.03B
| $4.26M | ﹤0.01% |
147,197
-3,792
| -3% | -$106K |
|
2408
NRC Health Common Stock
NRC
$469M
| $4.26M | ﹤0.01% |
250,707
+9,730
| +4% | +$165K |
|
2409
First Trust Intermediate Duration Investment Grade Corporate ETF
FIIG
$648M
| $4.25M | ﹤0.01% |
205,029
+19,813
| +11% | +$417K |
|
2410
BJ's Restaurants
BJRI
$1.45B
| $4.25M | ﹤0.01% |
121,081
-10,241
| -8% | -$410K |
|
2411
Kodiak Sciences
KOD
$2.6B
| $4.24M | ﹤0.01% |
111,341
+8,628
| +8% | +$223K |
|
2412
Viridian Therapeutics
VRDN
$2.5B
| $4.24M | ﹤0.01% |
216,525
+659
| +0.3% | +$19.6K |
|
2413
Marten Transport
MRTN
$1.24B
| $4.22M | ﹤0.01% |
321,717
-12,576
| -4% | -$161K |
|
2414
Liberty Live Group Series A
LLYVA
$9.66B
| $4.21M | ﹤0.01% |
45,905
+52
| +0.1% | +$4.57K |
|
2415
Intellia Therapeutics
NTLA
$1.67B
| $4.2M | ﹤0.01% |
328,000
+13,798
| +4% | +$176K |
|
2416
Ardelyx
ARDX
$1.05B
| $4.2M | ﹤0.01% |
700,783
-22,375
| -3% | -$148K |
|
2417
Kosmos Energy
KOS
$1.51B
| $4.19M | ﹤0.01% |
1,507,387
-17,648
| -1% | -$33.2K |
|
2418
iShares MSCI Brazil ETF
EWZ
$8.59B
| $4.18M | ﹤0.01% |
108,961
+5,371
| +5% | +$196K |
|
2419
AMN Healthcare
AMN
$1.34B
| $4.18M | ﹤0.01% |
227,840
-3,669
| -2% | -$69.7K |
|
2420
RLJ Lodging Trust
RLJ
$1.67B
| $4.16M | ﹤0.01% |
560,153
-83,916
| -13% | -$653K |
|
2421
NWPX Infrastructure Inc
NWPX
$1.12B
| $4.16M | ﹤0.01% |
53,379
-5,431
| -9% | -$392K |
|
2422
Liquidity Services
LQDT
$1.36B
| $4.14M | ﹤0.01% |
135,586
-5,994
| -4% | -$186K |
|
|
CAI
2423
Caris Life Sciences
CAI
$6.16B
| $4.14M | ﹤0.01% |
231,661
+181,258
| +360% | +$3.96M |
|
2424
Under Armour Class C
UA
$2.26B
| $4.13M | ﹤0.01% |
714,026
+8,163
| +1% | +$51.5K |
|
2425
Bahl & Gaynor Small/Mid Cap Income Growth ETF
SMIG
$1.52B
| $4.13M | ﹤0.01% |
+140,618
| New | +$4.25M |
|
Similar funds
Bank of New York Mellon's Q1 2026 Portfolio in Review
As of Q1 2026, Bank of New York Mellon held 4,358 positions worth $544B, down 4.2% from $568B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Bank of New York Mellon's Q1 2026 filing shows 177 new, 1,536 increased, 2,374 reduced and 164 closed positions. Its largest new stake was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B. The largest sale was Vanguard S&P 500 ETF, an estimated $2.06B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q1 2026 buy was BNY Mellon Municipal Opportunities ETF: 69,304,856 shares worth $1.71B.
- Bank of New York Mellon added most to AstraZeneca in Q1 2026, an estimated $1.19B increase.
- Bank of New York Mellon's biggest Q1 2026 reduction was Vanguard S&P 500 ETF, cutting an estimated $2.06B.
- Bank of New York Mellon fully exited Comerica in Q1 2026, selling an estimated $293M.
- Bank of New York Mellon's ten largest holdings make up 25% of its $544B portfolio in Q1 2026.
- Bank of New York Mellon opened 177 new positions and closed 164 in Q1 2026.
- Bank of New York Mellon's portfolio value fell 4.2% quarter-over-quarter to $544B.
Based on Bank of New York Mellon's 13F filing for Q1 2026, filed 5 May 2026.